文献速递神经外周血管CTMRUSDSA

2007至2017年急诊科神经影像使用率持续增长

Increasing Utilization of Emergency Department Neuroimaging From 2007 Through 2017.
PubMed 文献 · AJR Am J Roentgenol · 2021-08-04

年龄调整后总体使用率每1000次急诊就诊增加72%,头颈部CTA增长最为显著(头CTA增1100%,颈CTA增1300%),而颈动脉双功超声下降8%。

要点

  • 急诊神经影像总体使用率每年复合增长5%,头颈部CTA增速远超其他 modalities。
  • 平扫头CT仍是急诊神经影像的主导检查,使用率增长69%。
  • 颈动脉双功超声使用率下降8%,与其他神经影像增长趋势相反。

诊断标准与关键数值

  • 总体年龄调整后急诊神经影像使用率每1000次急诊就诊增加72%(复合年增长率5%)。
  • 头CT使用率增加69%(复合年增长率5%),头MRI增加67%(复合年增长率5%)。
  • 头CTA增加1100%(复合年增长率25%),颈CTA增加1300%(复合年增长率27%)。
  • 头MRA增加36%(复合年增长率3%),颈MRA增加52%(复合年增长率4%),颈动脉双功超声下降8%(复合年增长率-1%)。
  • 65岁及以上参保者头CT使用率增加48%(复合年增长率4%),头颈部CTA增加1011%(复合年增长率24%)。

临床应用与阅片要点

  • 急诊神经影像需求快速增长,尤其头颈部CTA,阅片时需关注CTA检查的适应证合理性。
  • 平扫头CT仍是急诊神经影像的主要检查,报告时应结合临床申请指征。
  • 颈动脉双功超声使用率下降,可能反映CTA替代趋势,需注意检查选择变化。

局限性

  • 基于理赔数据,缺乏临床指征和影像结果细节。
  • 仅纳入商业保险和Medicare Advantage人群,可能不适用于其他支付类型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. The volume of emergency department (ED) visits and the number of neuroimaging examinations have increased since the start of the century. Little is known about this growth in the commercially insured and Medicare Advantage populations. OBJECTIVE. The purpose of our study was to evaluate changing ED utilization of neuroimaging from 2007 through 2017 in both commercially insured and Medicare Advantage enrollees. METHODS. Using patient-level claims from Optum's deidentified Clinformatics Data Mart database, which annually includes approximately 12-14 million commercial and Medicare Advantage health plan enrollees, annual ED utilization rates of head CT, head MRI, head CTA, neck CTA, head MRA, neck MRA, and carotid duplex ultrasound (US) were assessed from 2007 through 2017. To account for an aging sample population, utilization rates were adjusted using annual relative proportions of age groups and stratified by patient demographics, payer type, and provider state. RESULTS. Between 2007 and 2017, age-adjusted ED neuroimaging utilization rates per 1000 ED visits increased 72% overall (compound annual growth rate [CAGR], 5%). This overall increase corresponded to an increase of 69% for head CT (CAGR, 5%), 67% for head MRI (CAGR, 5%), 1100% for head CTA (CAGR, 25%), 1300% for neck CTA (CAGR, 27%), 36% for head MRA (CAGR, 3%), and 52% for neck MRA (CAGR, 4%) and to a decrease of 8% for carotid duplex US (CAGR, -1%). The utilization of head CT and CTA of the head and neck per 1000 ED visits increased in enrollees 65 years old or older by 48% (CAGR, 4%) and 1011% (CAGR, 24%). CONCLUSION. Neuroimaging utilization in the ED grew considerably between 2007 and 2017, with growth of head and neck CTA far outpacing the growth of other modalities. Unenhanced head CT remains by far the dominant ED neuroimaging examination. CLINICAL IMPACT. The rapid growth of head and neck CTA observed in the fee-for-service Medicare population is also observed in the commercially insured and Medicare Advantage populations. The appropriateness of this growth should be monitored as the indications for CTA expand.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. ElHabr A, Merdan S, Ayer T, et al. Increasing Utilization of Emergency Department Neuroimaging From 2007 Through 2017. AJR Am J Roentgenol. 2021. PMID: 34346786. doi:10.2214/AJR.21.25864

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。